Circulating levels of pro-inflammatory cytokines [IL-6, high sensitivity CRP, IL-1β, Tumor Necrosis Factor-a (TNF-α)] are often increased in patients with MASLD, especially in MASH, indicating that low-grade systemic inflammation is a major component in disease progression [47]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatohepatitis.